Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients

Int J Biol Sci. 2023 Mar 5;19(6):1664-1680. doi: 10.7150/ijbs.78864. eCollection 2023.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection significantly affects the cardiovascular system, causing vascular damage and thromboembolic events in critical patients. Endothelial dysfunction represents one of the first steps in response to COVID-19 that might lead to cardiovascular complications and long-term sequelae. However, despite the enormous efforts in the last two years, the molecular mechanisms involved in such processes remain poorly understood. Herein, we analyzed the protein changes taking place in endothelial colony forming cells (ECFCs) after the incubation with the serum from individuals infected with COVID-19, whether asymptomatic or critical patients, by application of a label free-quantitative proteomics approach. Specifically, ECFCs from healthy individuals were incubated ex-vivo with the serum of either COVID-19 negative donors (PCR-/IgG-, n:8), COVID-19 asymptomatic donors at different infective stages (PCR+/ IgG-, n:8and PCR-/IgG+, n:8), or hospitalized critical COVID-19 patients (n:8), followed by proteomics analysis. In total, 590 proteins were differentially expressed in ECFCs in response to all infected serums. Predictive analysis highlighted several proteins like CAPN5, SURF4, LAMP2 or MT-ND1, as highly discriminating features between the groups compared. Protein changes correlated with viral infection, RNA metabolism or autophagy, among others. Remarkably, the angiogenic potential of ECFCs in response to the infected serums was impaired, and many of the protein alterations in response to the serum of critical patients were associated with cardiovascular-related pathologies.

Keywords: COVID-19; ECFCs; RNA metabolism; Viral infection; autophagy; cardiovascular diseases; endothelial dysfunction; mass spectrometry; proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Calpain
  • Cardiovascular System*
  • Cells, Cultured
  • Humans
  • Immunoglobulin G
  • Membrane Proteins
  • Proteomics
  • SARS-CoV-2

Substances

  • Immunoglobulin G
  • SURF4 protein, human
  • Membrane Proteins
  • Capn5 protein, human
  • Calpain